Malkamaki, Daniel

Malkamaki, Daniel was paid $72K by Medicaid between Nov 2022 and Dec 2023, across 5 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 57% of everything it billed.

33Billing provider infoMALKAMAKI, DANIEL
PITTSBURGH, PA 15238

33aNPI1487686382assigned 07/07/2006

33bProvider typePhysical Medicine & Rehabilitation Physician

28Total paid$72K

24GClaims1,417

24DCodes billed5

24AFirst – last monthNov 2022 – Dec 2023

Compared with peers

Next to other Physical Medicine & Rehabilitation Physician providers in Pennsylvania

Rank by total paid#29 of 148

Median peer was paid$8K

This provider vs. median9.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2022	116	$7K
2023	1,301	$65K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	57%	939	918	$41K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	17%	183	182	$12K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	16%	202	168	$12K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	5.8%	46	46	$4K
95886		4.0%	47	25	$3K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.